Difference between revisions of "Quell relief"
Jump to navigation
Jump to search
(→Important Dates: info update) |
(info updated) |
||
| Line 23: | Line 23: | ||
<tr> | <tr> | ||
<th scope="row">Announced</th> | <th scope="row">Announced</th> | ||
| − | <td>[[Announced in:: | + | <td>[[Announced in::Oct 2015]]</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<th scope="row">Released</th> | <th scope="row">Released</th> | ||
| − | <td | + | <td>Consumers: [[Released for consumers::2015]]</td> |
| − | |||
</tr> | </tr> | ||
Revision as of 13:54, 20 October 2015
| QUELL RELIEF | |
|---|---|
|
|
| Category | Therapeutic wearables |
| Developer | NeuroMetrix |
| Announced | Oct 2015 |
| Released | Consumers: 2015 |
| Price | 249 USD |
| Weight | 62 g |
| Dimensions | 98 x 74 x 11 mm |
| Controls | smartphone |
| Standalone[1] | |
| https://www.quellrelief.com/product | |
Contents
Main characteristics
Purpose
Company & People
Important Dates
1965 - Melzack and Wall proposed first conceptual model for mechanism which could lead to pain relief
1970s - Developement of TENS (Transcutaneous electrical nerve stimulation)
Ethical Issues
Health Risks
No health risks are known. Usage is 100% drug free, with clearance by FDA (Food and Drug Administration)
Enhancement/Therapy/Treatment
Quell wearable device has primarily therapeutical function. It was developed on purpose to palliate chronical pain which basically has origin in these four diseases:
Public & Media Impact and Presentation
Public Policy
Related Technologies, Project or Scientific Research
References
- ↑ Shows if the device is a standalone wearable computer or if it needs to be connected to a processing unit to function.
